approved EB-2 (NIW)

Senior Scientist

Medical Science · Bangladesh · 2022-04-15

Processing Time
126 days
Decision Date
2022-04-15
Location
Japan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on investigating the pathways that regulate healthy and cancerous cells. This work aims to develop new therapeutic drugs and organ transplant technologies, specifically focusing on identifying genetic markers associated with cancerous cell growth and proliferation.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on cancer stem cells and leukemia is of the utmost importance to U.S. health and safety.

2 Well-positioned to Advance the Endeavor Met

The petitioner has over 14 years of experience and a record of highly cited publications and major funding.

3 Waiver Benefit Met

On balance, the petitioner's contributions to life-saving medical technologies outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on 5 peer-reviewed journal articles (2 first-authored) and 170 citations demonstrating wide recognition. The petitioner has over 14 years of research experience and her work has received funding from major institutions like MEXT, MHLW, and NIBIOHN. Four expert recommendation letters further supported that her work meets the Dhanasar criteria.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Pennsylvania 103 days 2023-05-26
The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 111 days 2023-03-23
The petitioner proposes to continue her research in biomedical sciences, specifically optimizing therapeutic strategies for acute myeloid leukemia by elucidating molecular mechanisms. Her work focuses on identifying leukemia stem cell markers and critical transcription factors to develop advanced treatment strategies for therapy-resistant quiescent stem cells in blood cancer.

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 126 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist